- Intraocular Lenses
KEY TAKEAWAY POINTS
The PanOptix trifocal IOL utilizes a unique hybrid central non-apodized diffractive and peripheral refractive design with Enhanced Light Energy (ENLIGTHEN) technology to
Provide focal points at far distance, patient comfortable intermediate at 60 cm and near at 40 cm1,2
Provide 88% light utilization with less dependence on pupil size
The global pooled analysis shows bilateral implantation of the PanOptix IOL provides a continuous range of vision of 0.1 logMAR (Snellen 20/25) or better vision from distance to near at 33 cm, with low incidences of ocular adverse device effects and secondary surgical interventions3
Meta-analysis shows 92% cataract patients have complete spectacle independence4 and less than 3% cataract patients will experience very bothersome visual phenomena5 after bilateral implantation of the PanOptix IOLs
The PanOptix IOL provides a similar range of vision from distance to near at 33 cm in both photopic and mesopic conditions, with a better visual disturbance profile compared to Synergy IOL6,7
Implantation of PanOptix is a cost-beneficial treatment strategy to provide greater improvement in vision related quality of life compared to a monofocal IOL8